In LOAD2 mice on a high-fat diet, synapses go haywire even without Aβ plaques. ApoE-Christchurch variant bolsters protective ...

America's COVID celebrity is facing scrutiny for funding risky research that may have sparked the pandemic—and for allegedly ...

Monoclonal antibodies—treatments developed by cloning a cell that makes an antibody—could help provide an answer to the ...

Scientists in China have created a mutant strain of COVID-19 in a lab that has a 100% death rate for mice with human genes.

Using engineered mice, researchers developed monoclonal antibodies that were effective against infection with A. baumannii.

HIV-1 Vpu triggers the cleavage of TDP-43 by stimulating Caspase 3 activation. The cleavage products generated can induce the ...

Tangles of tau proteins in the brain are a hallmark of Alzheimer's disease, but recently, these crucial filaments have ...

Late-breaking data at WCLC show Libtayo monotherapy nearly doubled median overall survival and reduced the risks of death and disease progression ...

Tango Therapeutics is a high-risk, high-reward opportunity in the field of PRMT5-inhibitor drugs targeting MTAP-deleted ...

Following Priority Review, Dupixent is now available to patients as young as 12 years with inadequately controlled CRSwNPCurrent treatment ...